Regencell Bioscience (RGC) vs Tilray Brands (TLRY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Regencell Bioscience (RGC) has outperformed Tilray Brands (TLRY) over the past year, losing 60.7% versus a loss of 79.1%. Over five years, RGC leads with a +1455.6% price change compared with -96.5% for TLRY.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RGC | TLRY |
|---|---|---|
| Share price | $7.63 | $3.59 |
| Market cap | — | $530.54M |
| 1-day change | +7.31% | -3.36% |
| YTD return | -63.67% | -60.24% |
| 1-year return | -60.67% | -79.13% |
| 5-year return | +1455.56% | -96.49% |
| Forward P/E | — | 20.22 |
| EPS (TTM) | $-0.02 | $-1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-11.70M | — |
| 52-week high | $69.00 | $23.20 |
| 52-week low | $4.51 | $3.38 |
| Distance from 52-week high | -88.94% | -84.53% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +99.44% |
| Average volume | 199.19K | 4.07M |
| Shares outstanding | — | 147.78M |
| Employees | 10 | 3,595 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RGC has outperformed TLRY by 18.5 percentage points over the past year.
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
About Tilray Brands
TLRY stock →Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.
Health Care · Medicinal Chemicals and Botanical Products · 3,595 employees
RGC vs TLRY FAQ
Which stock has performed better over the past year, RGC or TLRY?
RGC returned -60.67% over the past 12 months, compared with -79.13% for TLRY (price return, excluding dividends). Past performance does not predict future results.
Are Regencell Bioscience and Tilray Brands in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.